Determination of the effect of pyocyanin and Saccharomyces boulardii on gut microbiota and TLR4/MyD88/NF-κB and NLRP3 signaling pathways in sepsis induced by cecal ligation and puncture in rats

ArticleAçık Erişim

Özet

Sepsis is a life-threatening systemic inflammatory condition marked by a dysregulated host response to infection. The intestinal microbiota plays a pivotal role in maintaining immune homeostasis and epithelial barrier integrity, whereas dysbiosis significantly contributes to the pathogenesis of sepsis. This study investigates the effects of the Pseudomonas aeruginosa-derived metabolite Pyocyanin and the probiotic Saccharomyces boulardii (S. boulardii) on microbial composition and the TLR4/MyD88/NF-κB/NLRP3 signaling axis in a cecal ligation and puncture (CLP)-induced rat model of sepsis. The experimental design assessed the synergistic or antagonistic effects of single and combined treatments using molecular, microbiome, and immunohistochemical parameters to evaluate histopathological damage and microbial ecological dynamics. Seven experimental groups were established following CLP. Intra-abdominal Pyocyanin (10 nmol/g) and oral probiotic (10⁶ CFU/kg) treatments were administered either individually or in combination. Focused Ion Beam - Scanning Electron Microscopy (FIB-SEM) analyses revealed that the amorphous structure of Pyocyanin interacted with the surface of S. boulardii. Western blot analysis showed a 2.3-fold increase in TLR4/NF-κB expression in the CLP group (p ≤ 0.05), which synergistically rose to 4.5-fold with Pyocyanin (p ≤ 0.001), whereas probiotic treatment decreased expression levels by 35%. According to 16 S rRNA sequencing, Pyocyanin reduced α-diversity by increasing Lactobacillaceae abundance to 32.66% (Shannon index: 3.598 vs. 4.433 in control), while S. boulardii enhanced β-diversity by elevating Coriobacteriaceae (5.85%) and Prevotellaceae (10.63%) levels (Tables 2, 3 and 4). PCoA confirmed 41.7% Bray-Curtis dissimilarity between groups at the species level (PERMANOVA R²=0.38, p = 0.002). Histopathologically, severe hepatocyte necrosis (73.2 ± 6.1%, p = 0.0022) and a 4.2-fold increase in hepatic TGF-β expression were observed in the CLP group, whereas epithelial barrier damage was significantly attenuated in the probiotic groups. Immunofluorescence analysis revealed that combined treatment reduced Caspase-8 and TLR4 expression by 28% compared to Pyocyanin alone (p ≤ 0.05). In conclusion, S. boulardii supported microbiota homeostasis by suppressing TLR4/NF-κB signaling, whereas Pyocyanin exacerbated the inflammatory response via NLRP3 activation. These findings provide molecular evidence supporting probiotic-assisted immunomodulatory strategies in sepsis therapy. © The Author(s) 2025.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11012Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1186/s12879-025-11308-4Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorUcar, Mahmut
dc.contributor.authorCelebi, Ozgur
dc.contributor.authorCelebi, Demet
dc.contributor.authorBaser, Sumeyye
dc.contributor.authorGuler, Mustafa Can
dc.contributor.authorTanyeli, Ayhan
dc.contributor.authorKılıclıoglu, Metin
dc.contributor.authorYılmaz, Ahmet
dc.contributor.authorYıldırım, Serkan
dc.date.accessioned2026-10-18T20:26:07.136564096Z
dc.date.available2026-10-18T20:26:07.136564096Z
dc.date.issued2025
dc.description.abstractSepsis is a life-threatening systemic inflammatory condition marked by a dysregulated host response to infection. The intestinal microbiota plays a pivotal role in maintaining immune homeostasis and epithelial barrier integrity, whereas dysbiosis significantly contributes to the pathogenesis of sepsis. This study investigates the effects of the Pseudomonas aeruginosa-derived metabolite Pyocyanin and the probiotic Saccharomyces boulardii (S. boulardii) on microbial composition and the TLR4/MyD88/NF-κB/NLRP3 signaling axis in a cecal ligation and puncture (CLP)-induced rat model of sepsis. The experimental design assessed the synergistic or antagonistic effects of single and combined treatments using molecular, microbiome, and immunohistochemical parameters to evaluate histopathological damage and microbial ecological dynamics. Seven experimental groups were established following CLP. Intra-abdominal Pyocyanin (10 nmol/g) and oral probiotic (10⁶ CFU/kg) treatments were administered either individually or in combination. Focused Ion Beam - Scanning Electron Microscopy (FIB-SEM) analyses revealed that the amorphous structure of Pyocyanin interacted with the surface of S. boulardii. Western blot analysis showed a 2.3-fold increase in TLR4/NF-κB expression in the CLP group (p ≤ 0.05), which synergistically rose to 4.5-fold with Pyocyanin (p ≤ 0.001), whereas probiotic treatment decreased expression levels by 35%. According to 16 S rRNA sequencing, Pyocyanin reduced α-diversity by increasing Lactobacillaceae abundance to 32.66% (Shannon index: 3.598 vs. 4.433 in control), while S. boulardii enhanced β-diversity by elevating Coriobacteriaceae (5.85%) and Prevotellaceae (10.63%) levels (Tables 2, 3 and 4). PCoA confirmed 41.7% Bray-Curtis dissimilarity between groups at the species level (PERMANOVA R²=0.38, p = 0.002). Histopathologically, severe hepatocyte necrosis (73.2 ± 6.1%, p = 0.0022) and a 4.2-fold increase in hepatic TGF-β expression were observed in the CLP group, whereas epithelial barrier damage was significantly attenuated in the probiotic groups. Immunofluorescence analysis revealed that combined treatment reduced Caspase-8 and TLR4 expression by 28% compared to Pyocyanin alone (p ≤ 0.05). In conclusion, S. boulardii supported microbiota homeostasis by suppressing TLR4/NF-κB signaling, whereas Pyocyanin exacerbated the inflammatory response via NLRP3 activation. These findings provide molecular evidence supporting probiotic-assisted immunomodulatory strategies in sepsis therapy. © The Author(s) 2025.
dc.identifier.doi10.1186/s12879-025-11308-4
dc.identifier.eissn1471-2334
dc.identifier.issn1471-2334
dc.identifier.issue1
dc.identifier.pmcidPMC12281731
dc.identifier.pmid40691769
dc.identifier.scopus2-s2.0-105011361152
dc.identifier.startpage931
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11012
dc.identifier.volume25
dc.identifier.wosWOS:001532882900002
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.ispartofBMC Infectious Diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGut microbiota
dc.subjectPyocyanin
dc.subjectSaccharomyces boulardii
dc.subjectSepsis
dc.subjectWestern blot
dc.subjectAnimals
dc.subjectCarrier Proteins
dc.subjectCecum
dc.subjectDisease Models, Animal
dc.subjectGastrointestinal Microbiome
dc.subjectLigation
dc.subjectMale
dc.subjectMyeloid Differentiation Factor 88
dc.subjectNF-kappa B
dc.subjectNLR Family, Pyrin Domain-Containing 3 Protein
dc.subjectProbiotics
dc.subjectPyocyanine
dc.subjectRats
dc.subjectRats, Sprague-Dawley
dc.subjectSignal Transduction
dc.subjectToll-Like Receptor 4
dc.subjectcaspase 8
dc.subjectcytochrome P450
dc.subjectdiaminobenzidine
dc.subjectDNA polymerase
dc.subjectimmunoglobulin enhancer binding protein
dc.subjectisoflurane
dc.subjectketamine
dc.subjectmyeloid differentiation primary response 88
dc.subjectprotein
dc.titleDetermination of the effect of pyocyanin and Saccharomyces boulardii on gut microbiota and TLR4/MyD88/NF-κB and NLRP3 signaling pathways in sepsis induced by cecal ligation and puncture in rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus5
rdl.citation.wos6
rdl.departmentDepartment of Pharmaceutical Microbiology, Erzincan Binali Yıldırım University, Faculty of Pharmacy, Erzincan, 24100, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)